Case Commentary: When one target is not enough-PBP3 insertions and target redundancy in Escherichia coli

Madison E Stellfox1, Yohei Doi1,2

  • 1Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Insights

Penicillin-binding protein 3 (PBP3) insertions in Escherichia coli reduce susceptibility to beta-lactam antibiotics, complicating treatment. Combination therapy with imipenem-relebactam and aztreonam successfully treated a patient with NDM-producing E. coli.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Penicillin-binding protein 3 (PBP3) insertions in Escherichia coli can confer resistance to beta-lactam antibiotics.
  • This resistance mechanism complicates treatment, especially when co-occurring with New Delhi metallo-beta-lactamase (NDM) production.

Purpose of the Study:

  • To highlight the clinical impact of PBP3 insertions in Escherichia coli.
  • To present a successful treatment strategy for a complex case of beta-lactam resistant E. coli.

Main Methods:

  • Case report of a patient with NDM-producing Escherichia coli.
  • Clinical assessment of treatment response to imipenem-relebactam plus aztreonam.

Main Results:

  • PBP3 insertions significantly reduced susceptibility to key beta-lactam agents.
  • Clinical improvement was achieved with the combination therapy of imipenem-relebactam and aztreonam.
  • Targeting multiple penicillin-binding proteins can overcome functional redundancy in resistance.

Conclusions:

  • PBP3-mediated resistance is clinically relevant in Gram-negative pathogens.
  • Novel treatment strategies are needed to address complex beta-lactam resistance.
  • Combination therapy targeting multiple penicillin-binding proteins shows promise for treating resistant infections.

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
48
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
477
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
7.1K